Skip to content
Peregrine
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact

Amit Alfasi

Momentis Surgical™ achieves two FDA clearances in two weeks

Read More
Nectin Therapeutics Secures Global License Agreement with Immunome, Inc.

Nectin Therapeutics secures global license agreement with Immunome, Inc.

Read More
Cordio Medical

Cordio Medical partners with Iron Nation

Read More
Restore Medical, FDA

Restore Medical receives FDA Breakthrough Device Designation for the ContraBand™ System

Read More
DairyX receives 1.5 million ILS grant from Israel Innovation Authority

DairyX receives 1.5 million ILS grant from Israel Innovation Authority

Read More
Insightec Secures $150 Million in Series G Financing to Drive Continued Growth

Insightec secures $150 million in Series G financing to drive continued growth

Read More
BRAIN.Q and Wanda Fish

BRAIN.Q and Wanda Fish recognized as the World Economic Forum’s technology pioneers for 2024

Read More
Wanda Fish makes waves with cultivated bluefin tuna toro sashimi

Wanda Fish makes waves with cultivated bluefin tuna toro sashimi

Read More
Peregrine Ventures is mentioning 23 years of making a difference

Peregrine Ventures is mentioning 23 years of making a difference

Read More

Trojan Bio

Read More
Page1 Page2 Page3 Page4 Page5
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
Linkedin-in
©All rights reserved to Peregrine 2026

site by: 

razgroup-logo